| The role of matrix metalloproteinases in renal diseases | Funda SAĞLAM | 109–114 |
| Hyponatremia; current diagnosis and treatment | Ferhan CANDAN, Mansur KAYATAŞ, Gürsel YILDIZ | 115–131 |
| Use of biphosphonates in pediatric nephrology biphosphonates in pediatric | Nurdan YILDIZ, Harika ALPAY | 132–141 |
| Renal transplant alıcılarında enkapsüle peritoneal skleroz gelişimi: Risk faktörleri ve klinik sonuçları | Kenan KEVEN, Kenan ATEŞ, Şule ŞENGÜL, İlhan KURULTAK, Selçuk HAZİNEDAROĞLU, Acar TÜZÜNER, Ebru UZ | 142–145 |
| Does dexpantenol protect the kidney from ischemia-reperfusion injury? | Mesut YAZICI, Nil ÇULHACI, Mukadder SERTER, Sezen ÖZKISACIK, Harun GÜRSOY | 146–149 |
| Kronik böbrek yetmezlikli hastalarda statinlerin pleiotropik etkilerinin değerlendirilmesi | Cengiz BAL, Sultan ÖZKURT, Mehmet SOYDAN, Özkan ALATAŞ, Garip ŞAHİN | 150–155 |
| Son dönem böbrek yetmezliği hastalarının 5 yıllık retrospektif analizi: Tek merkez deneyimi | Kültigin TÜRKMEN, Yalçın SOLAK, Ahmet KIZILTUNÇ, Süleyman TÜRK | 156–162 |
| The association between uric acid and vitamin D levels in patients with chronic kidney disease | Erkan ŞENGÜL, Emine BİNNETOĞLU, Ahmet YILMAZ | 163–167 |
| The frequency of metabolic syndrome in patients on continuous ambulatory peritoneal dialysis and the association of developing metabolic syndrome wıth dialysis duration | Hasan KAYABAŞI, YILDIRIM Yaşar, Zülfükar YILMAZ, İdris YILDIRIM, M. Emin YILMAZ, Ali Kemal KADİROĞLU | 168–172 |
| Immunosuppressive agents in the treatment of membranoproliferative glomerulonephritis | Tülin AKAGÜN, Yaşar ÇALIŞKAN, Halil YAZICI, Aydın TÜRKMEN, Nadir ALPAY, Berna YELKEN, Ömer KAYA | 173–177 |
| Affecting factors of arterial stiffness in living related kidney transplant recipients | Gökhan NERGİZOĞLU, Kenan KEVEN, Müge ÖZCAN, Selçuk HAZİNEDAROĞLU, Şule ŞENGÜL, Serpil Ergülü EŞMEN, Acar TÜZÜNER, Arzu ENSARİ | 178–186 |
| Hypertensıon prevalance in pregnant women refered to the gynecology and obstetrics clinic of a faculty of medicine |